Clinical trial
Systolic Hypertension in the Elderly Program (SHEP)
NCT00000514 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00000514 |
|---|---|
| Title | Systolic Hypertension in the Elderly Program (SHEP) |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Collaborators | National Institute on Aging (NIA) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Cerebrovascular Disorders, Heart Diseases, Hypertension |
| Intervention type | Drug |
| Interventions | chlorthalidone, atenolol, reserpine |
| Start date | Jun 1, 1984 |
| Completion | Oct 1, 1996 |
| First posted | Oct 28, 1999 |
| Last update posted | Apr 15, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: